BEZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS

CANNABINOID RECEPTOR MODULATORS

TETRACYCLIC COMPOUND

THIOSEMICARBAZATES AND USES THEREOF

Nitrogen-containing compound, electronic element and electronic device

FACTOR XIIA INHIBITORS

Compounds and uses thereof

BRAF INHIBITORS AS PARADOX BREAKERS

BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF

Pyrazole Derivatives for FGFR Inhibitor and Preparation Method Thereof

ENZYME INHIBITORS

ORGANIC ELECTRONIC DEVICE

SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2)

Hepatitis B capsid assembly modulators

SUBSTITUTED UREA DIHYDROOROTATE DEHYDROGENASE INHIBITORS

METHODS OF TREATING ELEVATED PLASMA CHOLESTEROL

HIGH THROUGHPUT METHOD FOR CONSTRUCTING AND SCREENING COMPOUND LIBRARY AND REACTION DEVICE

COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF

Compounds for the treatment of BRAF-associated diseases and disorders

ARYL SULFONAMIDES AS SMALL MOLECULE STAT3 INHIBITORS

HETEROCYCLIC COMPOUNDS AS MNK INHIBITORS

COMPOSITIONS OF NRF2 INHIBITING AGENTS AND METHODS OF USE THEREOF

Compounds for the treatment of BRAF-associated diseases and disorders

INHIBITORS OF TYROSINE KINASE

COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENT DEVICE AND APPLICATION THEREOF

CONJUGATE MONOMETHYL AURISTATIN E TO OBTAIN A COMPOSITION FOR TREATMENT OF PROSTATE CANCER

Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same

Bisamide sarcomere activating compounds and uses thereof

THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS

Lysophosphatidic acid receptor 1 (LPAR1) inhibitor compounds

HETEROCYCLIC COMPOUNDS AS KINASE INHIBITOR AND USES THEREOF

AURORA KINASE AND JANUS KINASE INHIBITORS FOR PREVENTION OF GRAFT VERSUS HOST DISEASE

Acetyl-CoA synthetase 2 (ACSS2) inhibitors and methods using same

NOVEL INHIBITORS

MASS SPECTROMETRY CLEAVABLE HETEROBIFUNCTIONAL PHOTOACTIVATED CROSS-LINKERS

Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof

SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS

PROTECTED TRIAZABUTADIENE COMPOSITIONS FOR CELLULAR STUDIES IN INTACT BIOLOGICAL SYSTEMS

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B

4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES

SULFONAMIDE DERIVATIVES AND USES THEREOF

Carboxylic acid compounds

UNSATURATED HETEROCYCLOALKYL AND HETEROAROMATIC ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF

COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS

Heterocyclic compounds for inhibiting TYK2 activities

Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d) pyridazine-3-carboxamide

BENZETHERS AND ANILINES OF PYRAZOLYL-AMINO-PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF

SARS-COV-2 MAIN PROTEASE INHIBITORS

Nitrile-containing antiviral compounds

NLRP3 inflammasome inhibitors

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

Tead inhibitors and uses thereof

1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS

Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof

BICYCLIC COMPOUND AS RIP-1 KINASE INHIBITOR AND APPLICATION THEREOF

CRYSTAL FORM AND SALT OF QUINAZOLINE COMPOUND AND PREPARATION METHOD THEREOF

WDR5 INHIBITORS AND MODULATORS

PROCESS FOR PREPARING XPO1 INHIBITORS AND INTERMEDIATES FOR USE IN THE PREPARATION OF XPO1 INHIBITORS

AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF

CRYSTALLINE SALT FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYLD3) PYRIDAZINE-3-CARBOXAMIDE

SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS

Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitors

2-METHYL-QUINAZOLINES

ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF

PYRIMIDINE DERIVATIVE INHIBITING GROWTH OF CANCER CELL AND MEDICINAL USE THEREOF

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

PD-L1 antagonist compound

HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

N-((HETEROARYL)METHYL)-1-TOSYL-1H-PYRAZOLE-3-CARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS

COMPOUNDS, COMPOSITIONS, AND METHODS

INHIBITORS FOR PROGRAMMED CELL NECROSIS AND PREPARATION METHOD THEREFOR AND USE THEREOF

Antagonists of the muscarinic acetylcholine receptor M

HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6

Compounds and methods for treating cancer

PROTEIN AND/OR PEPTIDE MODIFICATION MOLECULE

COMPOUND AS IRAK INHIBITOR

Novel compounds and methods of use treating fructose-related disorders or diseases

Inhibitors of the notch transcriptional activation complex and methods for use of the same

NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE

PROCESS FOR MANUFACTURING ALKYLENEAMINE COMPOUNDS

Substituted 5-Cyclopropyl-1H-pyrazole-3-yl-amine Derivatives as Selective CDK12/13 Inhibitors

Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

PRMT5 INHIBITOR COMPOUNDS

INHIBITORS OF CD40-CD154 BINDING

Curable composition, cured product, and compound

Sulfoximine glycosidase inhibitors

AROMATIC AMINE COMPOUND AND USE THEREOF IN PREPARATION OF AR AND BRD4 DUAL INHIBITORS AND REGULATORS

N-substituted indole derivatives as PGE2 receptor modulators

TAIRE FAMILY KINASE INHIBITORS AND USES THEREOF

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

MYST family histone acetyltransferase inhibitors

Solid forms of an HPK1 inhibitor

Inhibitors of cysteine proteases and methods of use thereof

PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS

INDAZOLES AS LRRK2 INHIBITORS

SMALL MOLECULE MODULATORS OF IL-17

Benzodiazepine derivatives and uses thereof

Prostaglandin receptor EP2 antagonists, derivatives, and uses related thereto

ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

Novel compounds and their uses as thyroid hormone receptor agonists

COMPOUNDS, COMPOSITIONS AND METHODS

METHOD FOR PRODUCING PYRROLE-IMIDAZOLE (POLY)AMIDE

Inhibitors of lysine specific demethylase-1

IMIDAZOLINE DERIVATIVES AS CXCR4 MODULATORS

RET kinase inhibitors

SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS

QUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER

Bicyclic pyridazinones and methods of use thereof

Compound for Specifically Enhancing Spatial Coupling Degree of TRPV4-KCa2.3 Complex and Use thereof

20-HETE FORMATION INHIBITORS

Azole derivatives as apelin receptor agonist

Oxindoles and methods of use thereof

Nitrile-containing antiviral compounds

HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE

Small molecule myristate inhibitors of Bcr-abl and methods of use

Pyrrole derivatives as PLK1 inhibitors

Compounds, compositions, and methods

Polymorphs of Selinexor

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING

FAK inhibitor and drug combination thereof

Substituted isoquinolines as rock kinase inhibitors

QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS

COMPOUND, COMPOSITIONS, AND METHODS

BRD4-JAK2 INHIBITORS

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

Compounds for the treatment of Alzheimer's disease

Bis-cyclic guanidines as antibacterial agents

BIARYL COMPOSITIONS IN COMBINATION WITH TAMOXIFEN AND METHODS FOR MODULATING A KINASE CASCADE

Small Molecule Modulators of RAS GTPase

Ketoamide compound and preparation method, pharmaceutical composition, and use thereof

Small molecule direct inhibitors of KEAP1-NRF2 protein-protein interaction

Sulfonylureas and related compounds and use of same

MYC-MAX INHIBITOR COMPOUND THERAPEUTICS FOR CANCER TREATMENT, METHODS AND USES ASSOCIATED THEREWITH

Viral replication inhibitors

BIS(DIAZIRINE) DERIVATIVES AS PHOTO-CROSSSLINKER FOR TREATING CORNEAL ECTATIC DISORDERS

NLRP3 INHIBITORS

2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS

Compositions and methods for inhibition of the JAK pathway

DIRECT AMPK ACTIVATORS

METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS

COLORING COMPOSITION, FILM, COLOR FILTER, AND SOLID-STATE IMAGING ELEMENT

Substituted Heterocyclyl Derivatives as CDK Inhibitors

Heterocyclic compounds as immunomodulators

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

CXCR4 gamete molecular structure and method thereof

SUBSTITUTED PYRROLIDINE AMIDES III

INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF

Tubulin inhibitors

Combinations and uses thereof

Functionalized materials and compounds

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

ANTIBACTERIAL COMPOUNDS

Nitrogen-containing compound, electronic element and electronic device

METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINEDIAMINE COMPOUNDS

Substituted Pyrazolo[3,4-d]Pyrimidines as Kinase Inhibitors

Functionalized peptides as antiviral agents

Hydrazide containing nuclear transport modulators and uses thereof

KDM1A inhibitors for the treatment of disease

TRIAZOLE COMPOUNDS AND PREPARATION METHOD THEREFOR AND USE THEREOF

5-MEMBERED HETEROARYL COMPOUNDS CONTAINING A HYDROXAMATE MOIETY AND THEIR USE

Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof

INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY

Pyrrole compounds

SUBSTITUTED REVERSE PYRIMIDINE BMI-1 INHIBITORS

Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases

METHYLLACTAM RING COMPOUND AND PHARMACEUTICAL USE THEREOF

BENZIMIDAZOLE COMPOUNDS AS C-KIT INHIBITORS

Aminocarbamoyl compounds for the treatment of viral infections

Platelet aggregation inhibitor, preparation and uses thereof

Pyrazole compounds as LSD1 inhibitors and applications thereof

EBNA1 inhibitors and methods using same

NITRIC OXIDE DONORS

Nitrile-containing antiviral compounds

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

Bicycloheptane pyrrolidine orexin receptor agonists

Compounds for treating proliferative diseases

CONDENSED PYRROLES AS NOVEL BROMODOMAIN INHIBITORS

AURORA KINASE INHIBITORS

PROCESSES FOR THE PREPARATION OF ARGINASE INHIBITORS AND THEIR SYNTHETIC INTERMEDIATES

TYROSINE KINASE INHIBITOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE

Amino pyrimidine derivatives

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS

HERBICIDALLY ACTIVE SUBSTITUTED PHENYLPYRIMIDINE HYDRAZIDES

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

Compounds and Their Use for Reducing Uric Acid Levels

BI-FUNCTIONAL NANOHYBRIDS

CRYSTALLINE FORMS OF 1-(1,2-DIMETHYLPROPYL)-N-ETHYL-5-METHYL-N-PYRIDAZIN-4-YL-PYRAZOLE-4-CARBOXAMIDE

METHODS AND COMPOSITIONS FOR SCREENING AND IDENTIFICATION OF SPLICING MODULATORS

Compound and organic light emitting device comprising the same

AMINOQUINAZOLINONE AND AMINOISOQUINOLINONE DERIVATIVES AND APPLICATION THEREOF

CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE

DOCK1-INHIBITING COMPOUND AND USE THEREOF

Polycyclic compound

Arylazole compound and pest control agent

ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF

FERROELECTRIC FLUORESCENT SELF-ASSEMBLY COMPOUND AND ORGANIC ELECTRONIC ELEMENT INCLUDING THE SAME

BISARYL LACTAMS AS NRF2 ACTIVATORS

2-aminoimidazole-phenyl derivatives useful for controlling microbial growth

INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION

2-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors

Biphenyl diaryl pyrimidine derivative with aromatic heterocyclic structure

HERBICIDAL COMPOUNDS

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

HETEROCYCLIC COMPOUNDS AS AHR MODULATORS

CO-CRYSTAL FORMS OF SELINEXOR

Substituted heterocycles as c-MYC targeting agents

HERBICIDAL 2-AZASPIRO[3-5]NONANE COMPOUNDS

Bicyclic compounds and their use in the treatment of cancer

2-heteroaryl aminoquinazolinone derivative

SUBSTITUTED PHENYLPROPENYL PYRIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL APPLICATIONS

2-aminoquinazolinone derivative

Compounds

BETA-CATENIN AND B-CELL LYMPHOMA 9 (BCL9) INHIBITORS

PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

2,3-DIHYDROISOINDOLE-1-CARBOXAMIDES USEFUL AS ROR-GAMMA MODULATORS

QUINOLINE DERIVATIVE HAVING INDOLEAMINE-2,3-DIOXYGENASE INHIBITORY ACTIVITY

OXETANYLPHENOXYQUINOLINES AND ANALOGUES

GLP-1 receptor modulators

CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE

SMALL MOLECULES TARGETING MUTANT MAMMALIAN PROTEINS

4-substituted phenyl-1,3,5-triazine derivatives as modulators of TrK receptors

Benzopyrazole compound used as RHO kinase inhibitor

Phenylpyrrolidinone formyl peptide 2 receptor agonists

MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN

Heterocyclic compound

CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USE

Inhibitors of platelet function and methods for use of the same

COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

CARBENE COMPOUND, CARBENE-METAL NANOPARTICLE COMPLEX AND PREPARATION METHOD THEREOF

Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors

Modulators of THR-β and methods of use thereof

Inhibitors of cysteine proteases and methods of use thereof

THYROID HORMONE RECEPTOR AGONISTS

SITE-SPECIFIC COVALENT CHEMICAL LIGATION TO MONOCLONAL AND POLYCLONAL IMMUNOGLOBULIN

1,2,4-TRIAZIN-3(2H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

BETA-ADRENERGIC RECEPTOR ALLOSTERIC MODULATORS

PqsR inverse agonists

BIARYL PIPERIDINE AMIDE COMPOUNDS AND METHODS OF USE THEREOF

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

PARP inhibitors for treating cancer and asthma

Inhibition of Olig2 activity

Inhibitors of EGFR and methods of use thereof

PYRIMIDINEDIONE COMPOUNDS

TLR8 agonist

Compounds and methods for inhibiting fascin

SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV

Savoury and mouthfulness taste enhancers

PREPARATION OF PYRIDAZINYL AMINE COMPOUND AND APPLICATION THEREOF

Inhibitor compounds for male contraception

Electron buffering material and organic electroluminescent device comprising the same

HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6

Voltage-dependent T-type calcium channel inhibitor

Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

Antiviral compounds

Small molecule inhibitors of Interleukin-4

INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE

COMPOUNDS WITH ANTIMICROBIAL ACTIVITY

Benzathine analogs

Functionalized materials and compounds

Process for Manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and Formulations Thereof

AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS

N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same

Substituted pyrimidines as matrix metalloproteinase-9 hemopexin domain inhibitors

PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF

Substituted pyrimidines as LRKK2 inhibitors

ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF

Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)

Inhibitors of RAF kinases

Heteroaromatic compounds and their use as dopamine D1 ligands

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

Aryl-n-aryl derivatives for treating a RNA virus infection

TRPV4 antagonists

Benzoimidazole derivatives as anticancer agents

Substituted phenazines and methods of treating cancer and bacterial diseases

Cyclic Ureas

DEUTERATED MGL-3196 COMPOUND AND USE THEREOF

Taire family kinase inhibitors and uses thereof

6-MEMBERED HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES

(S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases

Hetero-halo inhibitors of histone deacetylase

DEGRADERS THAT TARGET PROTEINS VIA KEAP1

Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity

TGF-ß INHIBITORS

Covalent immune recruiter compounds for immune cell recognition and associated uses

INHIBITORS OF TISSUE TRANSGLUTAMINASE 2 (TG2) AND USES THEREOF

Process for preparing 4-amino-pyridazines

Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands

Methods for treating Huntington's disease

Pharmaceutical compounds

Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof

Bcl-2 inhibitors

CDK2 inhibitors

2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES

STRAD-binding agents and uses thereof